If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.40
Bid: 111.80
Ask: 113.00
Change: -1.00 (-0.88%)
Spread: 1.20 (1.073%)
Open: 111.00
High: 114.60
Low: 111.00
Prev. Close: 113.40
SAGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final results of tender offer

30 Jun 2021 08:00

RNS Number : 5628D
SAGA PLC
30 June 2021
 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 (EU MAR) AND ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (UK MAR)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY U.S. PERSON OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (the United States) OR ANY OTHER JURISDICTION OR TO ANY OTHER PERSON WHERE OR TO WHOM IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT 

30 June 2021.

Saga plc announces final results of its tender offer for its £250,000,000 3.375 per cent. Notes due 2024

 

Saga plc (the Company) announces today the final results of its invitation to holders of its £250,000,000 3.375 per cent. Notes due 12 May 2024 (ISIN: XS1610655950) guaranteed by Saga Mid Co Limited and Saga Services Limited (the Notes) to tender their Notes for purchase by the Company for cash (subject to the satisfaction (without limitation) or waiver of the New Financing Condition on or prior to the Settlement Date) (the Offer).

The Offer was announced on 22 June 2021 and was made on the terms and subject to the conditions contained in the tender offer memorandum dated 22 June 2021 (the Tender Offer Memorandum) prepared by the Company. Capitalised terms used in this announcement but not defined have the meanings given to them in the Tender Offer Memorandum.

The Expiration Deadline of the Offer was 4.00p.m. London time on Tuesday, 29 June 2021.

As at the Expiration Deadline, the Company had received valid tenders of £173,489,000 in aggregate nominal amount of the Notes for purchase.

The Company now announces that (subject to the satisfaction (without limitation) or waiver of the New Financing Condition on or prior to the Settlement Date) the Final Acceptance Amount will be £100,000,000 in aggregate nominal amount of outstanding Notes. Accordingly, (subject to the satisfaction (without limitation) or waiver of the New Financing Condition on or prior to the Settlement Date), the Company will accept for purchase Notes validly tendered in the Offer subject to pro rata scaling at a Scaling Factor of 57.261 per cent., as further described in the Tender Offer Memorandum. 

Subject to the satisfaction (without limitation) or waiver of the New Financing Condition on or prior to the Settlement Date, the Purchase Price will be 100 per cent. of the principal amount of the Notes and the Company will also pay Accrued Interest Payments.

Subject to the satisfaction (without limitation) or waiver of the New Financing Condition on or prior to the Settlement Date, the expected Settlement Date for the Offer is Friday, 2 July 2021. Following settlement of the Offer, £150,000,000 in aggregate nominal amount of the Notes will remain outstanding.

 

Barclays Bank PLC (Telephone: + 44 (0) 20 3134 8515; Attention: Liability Management Group; Email: eu.lm@barclays.com) and HSBC Bank plc (Telephone: +44 (0) 20 7992 6237; Attention: Liability Management Group; Email: LM_EMEA@hsbc.com) are acting as Dealer Managers for the Offer and Lucid Issuer Services Limited (Telephone: +44 (0) 20 7704 0880; Attention: Harry Ringrose / Jacek Kusion; Email: saga@lucid-is.com) is acting as Tender Agent.

This announcement is released by the Company and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of EU MAR and UK MAR, encompassing information relating to the Offer described above. For the purposes of EU MAR, UK MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Victoria Haynes, Company Secretary of Saga plc.

LEI Number: 2138004WWUJN94K2LH95

DISCLAIMER This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire any securities is being made pursuant to this announcement. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Company, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEEAAKNAFDFEAA
Date   Source Headline
7th May 20244:32 pmRNSTotal Voting Rights
30th Apr 20249:15 amRNSIssue of Equity
17th Apr 20247:00 amRNSPreliminary Results
30th Jan 20247:00 amRNSTrading Update
26th Jan 20247:00 amRNSResponse to Media Coverage
15th Jan 20244:52 pmRNSHolding(s) in Company
21st Dec 20234:43 pmRNSHolding(s) in Company
21st Dec 20234:39 pmRNSDirector/PDMR Shareholding
21st Dec 20233:44 pmRNSDirectorate Change
8th Dec 202312:53 pmRNSHolding(s) in Company
28th Nov 20237:00 amRNSDirectorate Change
20th Nov 20234:00 pmRNSHolding(s) in Company
2nd Nov 20232:44 pmRNSDirector/PDMR Shareholding
17th Oct 202311:53 amRNSHolding(s) in Company
9th Oct 20237:00 amRNSDirectorate Change
27th Sep 20237:01 amRNSDirectorate Change
27th Sep 20237:00 amRNSInterim Results
9th Aug 20234:47 pmRNSDirector/PDMR Shareholding
9th Aug 20234:44 pmRNSTotal Voting Rights
1st Aug 20233:03 pmRNSIssue of Equity
26th Jul 20238:37 amRNSChange of Registered Office
22nd Jun 20232:38 pmRNSHolding(s) in Company
20th Jun 20233:53 pmRNSResults of 2023 Annual General Meeting
20th Jun 20237:00 amRNSAGM Trading Update
13th Jun 20235:00 pmRNSDirector/PDMR Shareholding
30th May 20232:19 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSNotice of AGM
18th Apr 20237:00 amRNSAnnual Report and Accounts and Strategic Report
4th Apr 20237:00 amRNSPreliminary Results
2nd Mar 20239:10 amRNSTermination of discussions with Open Insurance
10th Feb 20237:00 amRNSResponse to Media Coverage
24th Jan 20237:01 amRNSCapital Markets Event
24th Jan 20237:00 amRNSTrading Update
23rd Jan 20237:00 amRNSResponse to Media Coverage
28th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20227:00 amRNSDirectorate Change
17th Nov 20222:47 pmRNSHolding(s) in Company
17th Nov 20229:00 amRNSEstablishment of New Committee
18th Oct 202210:15 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20227:00 amRNSInterim Results
23rd Aug 20227:00 amRNSDirectorate Change
18th Jul 20225:08 pmRNSDirector/PDMR Shareholding
8th Jul 202210:50 amRNSDirector/PDMR Shareholding
5th Jul 20224:19 pmRNSResult of 2022 AGM
5th Jul 20227:00 amRNSDirectorate Change
5th Jul 20227:00 amRNSTrading Update
30th May 20229:00 amRNSNotice of 2022 AGM
3rd May 20225:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.